211 related articles for article (PubMed ID: 35658347)
1. [Association between the presence of solid or micropapillary components and survival outcome in stage ⅠA lung adenocarcinoma cases: a retrospective cohort study].
Jin KQ; Shen YR; Wu YM; Dai J; Liu XG; Li JQ; Chen LS; Jiang GN
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):587-592. PubMed ID: 35658347
[No Abstract] [Full Text] [Related]
2. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
Zhang H; Sun FH; Chen ZC; Wang Q
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
[No Abstract] [Full Text] [Related]
3. [Analysis of the effect of different pathological subtypes to prognosis in stage I pulmonary adenocarcinoma].
Jiang W; Xi J; Xu S; Lu S; Wang Q
Zhonghua Wai Ke Za Zhi; 2015 Oct; 53(10):737-41. PubMed ID: 26654304
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
6. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
[TBL] [Abstract][Full Text] [Related]
7. Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy.
Wang Y; Zheng D; Zheng J; Huang Q; Han B; Zhang J; Zhao H; Chen H
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1015-1023. PubMed ID: 29532227
[TBL] [Abstract][Full Text] [Related]
8. The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides.
Zombori T; Nyári T; Tiszlavicz L; Pálföldi R; Csada E; Géczi T; Ottlakán A; Pécsy B; Cserni G; Furák J
Virchows Arch; 2018 Jun; 472(6):949-958. PubMed ID: 29611055
[TBL] [Abstract][Full Text] [Related]
9. The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma.
Hou Y; Song W; Chen M; Zhang J; Luo Q; Um SW; Facchinetti F; Bongiolatti S; Zhou Q
Transl Lung Cancer Res; 2022 Jan; 11(1):64-74. PubMed ID: 35242628
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
Li R; Qiu J; Li Z; Li H; Tang Z; Yu W; Tian H; Sun Z
World J Surg Oncol; 2024 Jan; 22(1):32. PubMed ID: 38273367
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes following lobectomy, segmentectomy, and wedge resection based on pathological subtyping in patients with pN0 invasive lung adenocarcinoma ≤1 cm.
Song W; Hou Y; Zhang J; Zhou Q
Cancer Med; 2022 Dec; 11(24):4784-4795. PubMed ID: 35570370
[TBL] [Abstract][Full Text] [Related]
12. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
[TBL] [Abstract][Full Text] [Related]
13. [Value of PET/CT Combined with CT Three-dimensional Reconstruction
in Distinguishing Different Pathological Subtypes of Early Lung Adenocarcinoma].
You J; Zhang G; Gao X; Chen Y; Shu Y
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):468-474. PubMed ID: 34120430
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma.
Yoshiya T; Mimae T; Tsutani Y; Tsubokawa N; Sasada S; Miyata Y; Kushitani K; Takeshima Y; Murakami S; Ito H; Nakayama H; Okada M
Ann Thorac Surg; 2016 Nov; 102(5):1668-1673. PubMed ID: 27344277
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of micropapillary and solid histological subtype on patients undergoing curative resection for stage I lung adenocarcinoma according to the extent of pulmonary resection and lymph node assessment.
Jeon YJ; Lee J; Shin S; Cho JH; Choi YS; Kim J; Zo JI; Shim YM; Choi YL; Kim HK
Lung Cancer; 2022 Jun; 168():21-29. PubMed ID: 35462111
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
Ito H; Date H; Shintani Y; Miyaoka E; Nakanishi R; Kadokura M; Endo S; Chida M; Yoshino I; Suzuki H;
BMC Cancer; 2022 Aug; 22(1):875. PubMed ID: 35948946
[TBL] [Abstract][Full Text] [Related]
17. Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size.
Chen C; Fu S; Ni Q; Yiyang W; Pan X; Jing J; Zhao H; Rui W
Med Sci Monit; 2019 Nov; 25():9003-9011. PubMed ID: 31772147
[TBL] [Abstract][Full Text] [Related]
18. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
19. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
[TBL] [Abstract][Full Text] [Related]
20. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis.
Ito M; Miyata Y; Tsutani Y; Ito H; Nakayama H; Imai K; Ikeda N; Okada M
Lung Cancer; 2020 Mar; 141():107-113. PubMed ID: 32035371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
